| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1006546134 |
| P356 | DOI | 10.1038/SJ.GT.3302987 |
| P698 | PubMed publication ID | 17611587 |
| P5875 | ResearchGate publication ID | 6225381 |
| P2093 | author name string | Wang X | |
| Fechner H | |||
| Poller W | |||
| Weger S | |||
| Pinkert S | |||
| Sipo I | |||
| Suckau L | |||
| P2860 | cites work | Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions | Q24531466 |
| Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy | Q24535690 | ||
| Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis | Q24684374 | ||
| Expression of coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers | Q28144562 | ||
| Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis | Q28213353 | ||
| Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors | Q30975099 | ||
| Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by rac1 and phosphatidylinositol-3 kinase activation | Q33604753 | ||
| Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2. | Q33781976 | ||
| Impaired intracellular trafficking of adeno-associated virus type 2 vectors limits efficient transduction of murine fibroblasts | Q33796712 | ||
| Adeno-associated virus type 2-mediated gene transfer: altered endocytic processing enhances transduction efficiency in murine fibroblasts | Q33839187 | ||
| Molecular characterization of adeno-associated viruses infecting children | Q34142840 | ||
| Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo | Q34277742 | ||
| Systemic delivery of genes to striated muscles using adeno-associated viral vectors. | Q34347199 | ||
| AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection | Q34486863 | ||
| Identification and characterization of novel adeno-associated virus isolates in ATCC virus stocks | Q34647917 | ||
| Alpha2,3 and alpha2,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6 | Q35024289 | ||
| Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8. | Q35025591 | ||
| The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9 | Q35101411 | ||
| Single amino acid changes can influence titer, heparin binding, and tissue tropism in different adeno-associated virus serotypes | Q35139648 | ||
| Second-strand genome conversion of adeno-associated virus type 2 (AAV-2) and AAV-5 is not rate limiting following apical infection of polarized human airway epithelia | Q35150199 | ||
| Intracellular trafficking of adeno-associated viral vectors. | Q36097743 | ||
| Chronic phospholamban inhibition prevents progressive cardiac dysfunction and pathological remodeling after infarction in rats. | Q36441343 | ||
| Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors | Q36509889 | ||
| Role of cellular FKBP52 protein in intracellular trafficking of recombinant adeno-associated virus 2 vectors | Q37005491 | ||
| Adeno-associated viral vector delivers cardiac-specific and hypoxia-inducible VEGF expression in ischemic mouse hearts | Q37610441 | ||
| Intracellular viral processing, not single-stranded DNA accumulation, is crucial for recombinant adeno-associated virus transduction | Q37682933 | ||
| Adeno-associated virus-mediated gene transfer of the heart/muscle adenine nucleotide translocator (ANT) in mouse | Q39371961 | ||
| Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors | Q39589898 | ||
| Adenovirus-facilitated nuclear translocation of adeno-associated virus type 2. | Q39685806 | ||
| Adeno-associated virus 2-mediated gene transfer: role of a cellular serine/threonine protein phosphatase in augmenting transduction efficiency | Q40205113 | ||
| Metabolic biotinylation provides a unique platform for the purification and targeting of multiple AAV vector serotypes | Q40290223 | ||
| Adeno-associated virus types 5 and 6 use distinct receptors for cell entry | Q40330670 | ||
| Impaired nuclear transport and uncoating limit recombinant adeno-associated virus 2 vector-mediated transduction of primary murine hematopoietic cells. | Q40463241 | ||
| Myocardial gene transfer and long-term expression following intracoronary delivery of adeno-associated virus | Q40498312 | ||
| Hepatocyte growth factor receptor is a coreceptor for adeno-associated virus type 2 infection. | Q40726384 | ||
| Infection of purified nuclei by adeno-associated virus 2. | Q40775943 | ||
| High-level transgene expression in nonhuman primate liver with novel adeno-associated virus serotypes containing self-complementary genomes | Q42424212 | ||
| rAAV2 traffics through both the late and the recycling endosomes in a dose-dependent fashion | Q43108748 | ||
| Real-time single-molecule imaging of the infection pathway of an adeno-associated virus | Q43812869 | ||
| Efficacy and safety of adeno-associated viral vectors based on serotype 8 and 9 vs. lentiviral vectors for hemophilia B gene therapy | Q44405190 | ||
| Widespread and early myocardial gene expression by adeno-associated virus vector type 6 with a beta-actin hybrid promoter. | Q44453756 | ||
| Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo | Q45413958 | ||
| Suppression of atherogenesis by delivery of TGFbeta1ACT using adeno-associated virus type 2 in LDLR knockout mice | Q45417393 | ||
| Chronic recurrent myocardial ischemic injury is significantly attenuated by pre-emptive adeno-associated virus heme oxygenase-1 gene delivery | Q45420121 | ||
| High levels of persistent expression of alpha1-antitrypsin mediated by the nonhuman primate serotype rh.10 adeno-associated virus despite preexisting immunity to common human adeno-associated viruses | Q45422901 | ||
| Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart | Q45507049 | ||
| Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6. | Q45571369 | ||
| Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield | Q45747699 | ||
| A novel tetracycline-controlled transactivator-transrepressor system enables external control of oncolytic adenovirus replication | Q45864768 | ||
| Biology of AAV serotype vectors in liver-directed gene transfer to nonhuman primates. | Q45887588 | ||
| Sustained whole-body functional rescue in congestive heart failure and muscular dystrophy hamsters by systemic gene transfer | Q45887681 | ||
| Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery | Q45888008 | ||
| Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors. | Q51278877 | ||
| Persistent liver expression of murine apoA-l using vectors based on adeno-associated viral vectors serotypes 5 and 1. | Q54648839 | ||
| Robust Adenoviral and Adeno-Associated Viral Gene Transfer to the In Vivo Murine Heart | Q58198543 | ||
| Heme oxygenase-1 (HO-1) inhibits postmyocardial infarct remodeling and restores ventricular function | Q95821951 | ||
| P433 | issue | 18 | |
| P921 | main subject | vector-borne disease | Q2083837 |
| P304 | page(s) | 1319-1329 | |
| P577 | publication date | 2007-07-05 | |
| P1433 | published in | Gene Therapy | Q15763095 |
| P1476 | title | Differential internalization and nuclear uncoating of self-complementary adeno-associated virus pseudotype vectors as determinants of cardiac cell transduction | |
| P478 | volume | 14 |
| Q35132004 | A novel artificial microRNA expressing AAV vector for phospholamban silencing in cardiomyocytes improves Ca2+ uptake into the sarcoplasmic reticulum. |
| Q42225050 | AAV8 capsid variable regions at the two-fold symmetry axis contribute to high liver transduction by mediating nuclear entry and capsid uncoating. |
| Q38685537 | Adeno-Associated Virus Vectors and Stem Cells: Friends or Foes? |
| Q34132686 | Adeno-associated virus (AAV) serotype 9 provides global cardiac gene transfer superior to AAV1, AAV6, AAV7, and AAV8 in the mouse and rat. |
| Q39973047 | Cardiac-targeted RNA interference mediated by an AAV9 vector improves cardiac function in coxsackievirus B3 cardiomyopathy |
| Q93081530 | Cell-specific CRISPR-Cas9 activation by microRNA-dependent expression of anti-CRISPR proteins |
| Q97527308 | Effects of Thermally Induced Configuration Changes on rAAV Genome's Enzymatic Accessibility |
| Q43173416 | Enhancement of adeno-associated virus infection by mobilizing capsids into and out of the nucleolus |
| Q98292031 | Gene Therapy Preserves Retinal Structure and Function in a Mouse Model of NMNAT1-Associated Retinal Degeneration |
| Q83556143 | Gene therapy for heart failure |
| Q40516718 | Genome-wide computational analysis reveals cardiomyocyte-specific transcriptional Cis-regulatory motifs that enable efficient cardiac gene therapy |
| Q35734826 | Intracellular transport of recombinant adeno-associated virus vectors |
| Q88540277 | Myoediting: Toward Prevention of Muscular Dystrophy by Therapeutic Genome Editing |
| Q35621815 | Percutaneous transendocardial delivery of self-complementary adeno-associated virus 6 achieves global cardiac gene transfer in canines. |
| Q34166253 | RH10 provides superior transgene expression in mice when compared with natural AAV serotypes for neonatal gene therapy |
| Q36953325 | Recombinant adeno-associated virus transduction and integration |
| Q34593758 | Recombinant adeno-associated virus utilizes cell-specific infectious entry mechanisms |
| Q59352976 | Reverse transduction can improve efficiency of AAV vectors in transduction-resistant cells |
| Q34804660 | Self-complementary AAV vectors; advances and applications |
| Q35431994 | Self-complementary adeno-associated viral vectors for gene therapy of hemophilia B: progress and challenges |
| Q28579249 | Terminal differentiation of cardiac and skeletal myocytes induces permissivity to AAV transduction by relieving inhibition imposed by DNA damage response proteins |
| Q37804497 | The next step in gene delivery: Molecular engineering of adeno-associated virus serotypes |
| Q39406314 | Unique characteristics of AAV1, 2, and 5 viral entry, intracellular trafficking, and nuclear import define transduction efficiency in HeLa cells. |
| Q30398001 | Vaccine protection against lethal homologous and heterologous challenge using recombinant AAV vectors expressing codon-optimized genes from pandemic swine origin influenza virus (SOIV). |
| Q43703662 | microRNA122-regulated transgene expression increases specificity of cardiac gene transfer upon intravenous delivery of AAV9 vectors |
Search more.